Friends of Cancer Research Senate Briefing – Turning the Tables: Innovator Meets Regulator A Dialogue with Stakeholders & FDA on Keeping Pace with Innovation & Patient Needs Dirksen Senate Office Building Room 430Washington, DC 20002 Tuesday, December 10, 2019 12:00 PM EST – 1:00 PM EST Lunch will be provided. Register Today! Speakers: Dr. Josh…
To access a recap of this past event, please Click HERE. Friends of Cancer Research Congressional Briefing Safeguarding the Public Health: Enhancing Information About Prescription Drugs Hart Senate Office Building Room 216 Washington, DC, 20002 Tuesday, March 20, 2018 2:00 PM – 3:30 PM EDT Patients, caregivers and their physicians and nurses need high quality…
Please join the National Coalition for Cancer Research and the American Association for Cancer Research for our upcoming “Cancer 101” Congressional Briefing Series event: The Cancer Moonshot Initiative: Current and Future Cancer Research Objectives Monday, March 20, 2017 12:00 -1:30 pm 2045 Rayburn House Office Building (formerly B-340) Register at msmith@libertypartnersgroup.com Lunch will be served…
On September 20th, 2016, the Senate Health, Education, Labor and Pensions Committee convened a hearing to discuss laboratory testing the in the era of precision medicine. The hearing took place amid an ongoing debate over the proper regulatory framework for laboratory-developed tests (LDTs). LDTs are in vitro diagnostic tests (IVDs) that are made and performed…
Senate Briefing The Future of Precision Medicine & Patient Care: Current Landscape in Genomic Testing Thursday, October 13th, 2016 – 12:00pm-1:00pm 430 Dirksen Senate Office Building Washington, DC On Thursday, October 13th, 2016, Friends of Cancer Research and the Deerfield Institute convened a briefing on Capitol Hill to discuss current and future regulatory issues related…
Please join the National Coalition for Cancer Research & One Voice Against Cancer for a Lunch briefing and Panel Discussion regarding the National Cancer Moonshot Blue Ribbon Panel Report Special Guest Speaker: Douglas R. Lowy, M.D. Acting Director National Cancer Institute Tuesday, September 27 from 12:00 – 1:30 pm EDT…
Please join the National Coalition for Cancer Research for their upcoming “Cancer 101” Congressional Briefing Series event: The Cancer “Moonshot” Initiative: New Frontiers in Cancer Exploration Monday, April 25, 2016 12:00 – 1:30 pm 485 Russell Senate Office Building RSVP at nccrcoalition@gmail.com Lunch will be served at this widely-attended event. President Obama has issued a…
Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies Tuesday, April 12, 2016 – 12:30pm-2:00pm Capitol Visitor’s Center, Room SVC 212-10 Washington, DC 20515 A Friends of Cancer Research Senate Briefing on the FDA’s breakthrough therapy designation Limited space is available. Register Now! Opening Keynote by Senator Michael Bennet (D-CO) Panelists: Janet Woodcock, Director, Center…
Centers of Excellence at the FDA: A Disease-Oriented Approach to Medical Product Development A Friends of Cancer Research (Friends) Senate Briefing on Opportunities for Cross-Center Coordination at the FDA to Reflect Current Patient Care February 24, 2016 – 11:00am-12:00pm US Capitol Visitors Center, SVC201-00 – Washington, DC Event Summary: Congress has not modernized FDA’s organizational structure for medical…
On May 6th, Friends of Cancer Research (Friends) hosted a congressional briefing entitled, “Science and Progress at the FDA: A Friends of Cancer Research Congressional Briefing on the Progress of the FDA’s Breakthrough Therapy Program.” The event was sponsored by Senators Michael Bennet (D-CO), Orrin Hatch (R-UT), and Richard Burr (R-NC), who together introduced the initial legislative…
